Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04599452
Other study ID # 2020NKAML
Secondary ID
Status Not yet recruiting
Phase Phase 1/Phase 2
First received
Last updated
Start date December 1, 2020
Est. completion date December 30, 2023

Study information

Verified date October 2020
Source The Second Hospital of Shandong University
Contact Chengyun Zheng, Ph.D
Phone +86-531-85875502
Email chengyun.zheng@ki.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this investigation was to assess safety and efficacy of allogenic NK cells therapy for recurrent refractory elderly AML.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date December 30, 2023
Est. primary completion date December 30, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years to 70 Years
Eligibility Inclusion Criteria: 1. The 2 or more than 2-cycles of standard regimen was used to treat elderly AML patients who did not achieve complete remission or relapse. 2. Patients with age 60 years to 70 years. 3. KPS greater than or equal to 60. 4. ALT and AST are less than 3 times normal. 5. Total bilirubin less than 1.5mg/dl(25.65umol/L). 6. Serum creatinine less than 2.5mg/dl(221umol/L), or creatinine scavenging ability greater than or equal to 60 mL/min/1.73 m2. 7. Left ventricular ejection fraction cardiac greater than or equal to 45%, Echocardiography (ECHO) showed no pericardial effusion, Electrocardiogram (ECG) is normal. 8. No pleural effusion in lungs 9. Oxyhemoglobin saturation greater than or equal to 92% in normal environment. 10. KIR mismatch between patient and umbilical cord blood. 11. Volunteer to participate in the trial and sign the informed consent form. Exclusion Criteria: 1. Malignant tumor patient. 2. Patients who are accompanied by fungal, bacterial, viral, or other uncontrolled infections or require level 4 isolation( HBV-DNA quantification and normal liver function in patients with hepatitis b infection are excluded). 3. Patients with HIV, HCV positive. 4. Patients with central nervous system diseases, including stroke, epilepsy, dementia, or autoimmune central nervous system disorders. 5. During the first 12 months of enrollment, patients with cardioangiography or stents, active angina pectoris or other clinically significant symptoms, or with cardiogenic asthma. 6. Patients receiving anticoagulant therapy or with severe coagulation disorders. 7. According to the researcher's judgment, the drug treatment the patient is receiving will affect the safety and effectiveness of the study. 8. Patients with allergies or history of allergies to biological agents used in this program. 9. Systemic steroid used within 2 weeks before treatment (except for recent or present use of inhaled corticosteroids). 10. Patients with other uncontrolled diseases, Investigators think it is not suitable for the participants. 11. Any circumstance that the investigator considers may increase the risk to the subject or interfere with the results of the study. 12. Patients participate in other clinical studies.

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Allogeneic NK cell regimen group
10 patients with recurrent refractory elderly AML were treated with allogeneic NK cell regimen. Allogeneic NK cell regimen ×3 cycle; Cyclophosphamide 300mg/m2.d d1to 3; G-CSF 150ug bid d4-11; Azacitidine 75mg/m2 d5-11; Allogeneic NK cell 10-30×10^6/kg d13,d15.

Locations

Country Name City State
China The 2nd Hospital of Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
The Second Hospital of Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective Response Rate (ORR) (PR+CR) The proportion of patients with complete response(CR) or partial response(PR) as measured by response criteria definitions for acute myeloid leukemia 3 months
Secondary Overall survival(OS) The proportion of patients with overall survival(OS). 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05531396 - Agility Training on Physical Performance, Cognitive Function and Brain Activities in Elderly N/A
Completed NCT03580447 - The Effect of Citrus Extract on Oxidative Stress N/A
Recruiting NCT04096547 - Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
Completed NCT03339791 - Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial N/A
Completed NCT03566719 - Effect of an Exercise Program on Risk of Fall in a Community Dwelling Older Adults N/A
Completed NCT02138968 - Clinical and Economic Assessment of a Pre-frail Screening Program N/A
Completed NCT01368029 - Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine Phase 1
Not yet recruiting NCT01182961 - The Use of Virtual Reality for the Gait Training of Elderly Fallers N/A
Completed NCT00961012 - The Big Squeeze (Lessening the Big Squeeze: The Effect of the Trunk Release on Interface Pressures of Individuals Seated in a High Fowler's Positions) N/A
Completed NCT01899586 - Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly N/A
Completed NCT00748683 - Development of an Integrated Health Care Environment for Elderly With RFID Technology Phase 0
Completed NCT00533065 - Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone N/A
Completed NCT00798668 - The Body's Response to Food Intake in Trained, Older Adults N/A
Completed NCT00324701 - Telepsychology-Service Delivery for Depressed Elderly Veterans N/A
Completed NCT00217113 - An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly N/A
Completed NCT03666793 - Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care N/A
Recruiting NCT06030804 - Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery N/A
Recruiting NCT05014750 - Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
Completed NCT05021432 - Virtual Reality And Task Oriented Circuit Training Among Elderly Population N/A
Active, not recruiting NCT04132492 - AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients